Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), announces the departure of Ms. Barinder Rasode as President and as a director of the Company, effective immediately.
The Company also announces that its Chief Executive Officer, Mr. Tim Moore, has been appointed as a director of the Company.
Ms. Rasode commented, “We created Havn Life to benefit human health and harness the medicine found in nature. I am so pleased with how far we have come in such a short time. It was always my intention to leave once the right team was in place and the Company well-positioned for success. That time has come, and I leave with confidence and excitement about the Company’s future.”
Mr. Vic Neufeld, Chairman of the Board of Havn Life, commented, “I’d like to thank Barinder for her vision in co-founding the Company and for her contributions toward realizing that vision, and I look forward to her continued support as a shareholder. The Company is extremely fortunate to have in Tim Moore a CEO who has a deep understanding of the biotechnology industry and who has demonstrated time and again the ability to achieve operational milestones while keeping key stakeholders and the wider investment community thoroughly engaged. It’s a pleasure to welcome Tim to the Board. We are very excited to strengthen his leadership of the Company and for the future of Havn Life.”
Mr. Tim Moore commented, “I welcome the opportunity to join the Havn Life Board. We have laid the foundation for continued good governance, with four of five Board members remaining independent of management, and I look forward to adding value in this new capacity as we pursue execution of our business plan.”
On Behalf of The Board of Directors
Eli Dusenbury
About Havn Life Sciences Inc.
Havn Life Sciences is a Canadian biotechnology company pursuing standardized extraction of psychoactive compounds, the development of natural healthcare products, and innovative mental health treatment to support brain health and enhance the capabilities of the mind. Learn more at: havnlife.com and follow us on Facebook, Twitter, Instagram and Youtube.
Connect
Investor Relations
ir@havnlife.com
(604) 687-7130
Facebook: @havnlife
Twitter: @havnlife
Insta: @havn.life
LinkedIn: @Havn Life
Youtube: @HavnLife
Media Contact
savi@emergence-creative.com
(647) 896-8078
v
The post Havn Life Announces Changes to Board Composition and Departure of Ms. Rasode appeared first on HAVN Life.
Learn more about the psychedelics industry at Microdose.